Ledger.Open graph →
SEC Form D · Amendment · filed July 2, 2015

Triangle Therapeutics Inc

Offering
$6.0M
Sold
$4.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LOS ANGELES, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Caius L. Radu · Los Angeles, CADirectorJohannes L. Czernin · Los Angeles, CADirectorLouis L. Gonda · Los Angeles, CADirectorJean L. Dekernion · Los Angeles, CADirectorCarl Mckinzie · Los Angeles, CAExec · DirectorJohn O. Maggard · New York, NYExec · DirectorColin Hunter · Richmond, VADirectorWilliam J. Ferri · New York, NYDirectorC. P. Jenkins · Richmond, VADirectorNorman S. Matthews · Burlingame, CAExec · DirectorPatricia E. Nakache · Menlo Park, CADirectorCynthia E. Ringo · San Francisco, CADirectorDavid Gray · Pompano Beach, FLDirectorDaniel Ellis · Ann Arbor, MIDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗